Company Announcements

Acquisition of remaining minority interest

Source: RNS
RNS Number : 2196Q
Benchmark Holdings PLC
17 February 2023
 

RNS Reach

17 February 2023

Benchmark Holdings plc

("Benchmark", the Group, or the "Company")

Acquisition of remaining minority interest in Benchmark Genetics Iceland

Benchmark Holdings, the aquaculture biotechnology company, announces that it has acquired the remaining 10.52% minority interest in its subsidiary Benchmark Genetics Iceland. Enhanced by the recent construction of a new incubation centre, Benchmark Genetics Iceland is core to the Company's ability to supply highly specialist, biosecure salmon eggs to salmon producers to c.35 countries around the world, year-round. Benchmark Genetics Iceland represents 50% of the Group's salmon egg capacity.

Background

In December 2014 Benchmark acquired a 89.48% interest in Stofnfiskur, subsequently rebranding it Benchmark Genetics Iceland and merging it with its salmon genetics business in Norway. Since the acquisition, the business has grown substantially, benefitting from Benchmark's leading market position, investment and knowledge transfer within the Group. 

Trond Williksen commented:

"Benchmark's genetics operations in Iceland have a 200m egg capacity and are core to our ability to supply highly biosecure salmon eggs year round to customers around the world. The acquisition of the remaining minority interest is a natural step in delivering shareholder value through full ownership of the success of our genetics business."

Rabobank acted as financial adviser to Benchmark in the transaction.

Enquiries

For further information, please contact:


Benchmark Holdings plc

Tel:  020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations




Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith


 


MHP

Tel:  020 3128 8004

Katie Hunt, Reg Hoare, Veronica Farah           

benchmark@mhpgroup.com

 

About Benchmark 

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare.

Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark serves major aquaculture species - salmon, shrimp, sea bass and bream and tilapia - in main aquaculture regions around the world. Find out more at www.benchmarkplc.com



 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRATFMBTMTBBTRJ